Apex Trials

Clinical Trial Site/Site NetworkPrivate Company
Guelph, Canada
2002
Founded
50-200
Employees

About Apex Trials

Apex Trials is a phase 1-4 dedicated research site based in Guelph, Ontario, Canada. Apex Trials has been running clinical trials for 15 years. Dr. Anthony Bier has been a PI for 9 years and is an emergency medicine specialist. Our sub-Is are Dr. Ken Woo (Family medicine) and Dr. Maria Casale (sexual health). Large facility, well resourced and experienced team. Fast start up with central IRB and in-house contract and budget. Key therapeutic areas: vaccines, cardiovascular, weight management, PK, metabolic (diabetes), allergies, respiratory, psychedelics and cannabis. Diverse database: 23% Asian, 9% Black, 2% Indigenous

Therapeutic areas

Experience & capabilities

Products:Point of Care TestingCompanion DiagnosticsMedical DevicesTherapeutic productsVaccines
Trial geography:North AmericaCanada
Languages:English

Team

  • Anthony BierPI
  • Josh BaisleySVP Clinical OperationsLinkedIn
  • Katie KeeneClinic supervisorLinkedIn

Browse companies by location

Guelph, CanadaCanada

Similar Clinical Trial Site/Site Network companies in Canada

CaRe Clinic

Clinical Trial Site/Site Network
Calgary, Canada·10-50 employees

We partner together with academic centres and pharmaceutical companies to help make new treatments available for patients. Our core research areas include: women’s health,…

Centre for Neurology Studies

Clinical Trial Site/Site Network
Surrey, Canada·1-10 employees

The CNS is a site for clinical trials in pharmaceuticals (phase II, III, and IV), medical devices (all phases), natural health products, and other novel therapeutics related to…

Clincove

Clinical Trial Site/Site Network
Toronto, Canada·10-50 employees

DermResearch, P.A.

Clinical Trial Site/Site Network
Austin, United States·10-50 employees

For over 25 years, DermResearch has been a leader in complex Phase 1-3 trials. We have a Phase 1 unit attached to our outpatient clinic for our healthy & dermatology studies. We…